Patents by Inventor Gregoire Couvrat-Desvergnes

Gregoire Couvrat-Desvergnes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition with reduced immunogenicity
    Patent number: 11084871
    Abstract: The present invention relates to a composition comprising polyclonal antibodies directed against human cells, wherein the said polyclonal antibodies are devoid of a first antigenic determinant selected in a group comprising (i) N-glycol-neuraminic acid (Neu5Gc) and (ii) ?-1,3-galactose and its use as a medicament.
    Type: Grant
    Filed: April 17, 2014
    Date of Patent: August 10, 2021
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Jean-Paul Soulillou, Magali Giral, Gregoire Couvrat-Desvergnes
  • Composition with Reduced Immunogenicity
    Publication number: 20160075770
    Abstract: The present invention relates to a composition comprising polyclonal antibodies directed against human cells, wherein the said polyclonal antibodies are devoid of a first antigenic determinant selected in a group comprising (i) N-glycol-neuraminic acid (Neu5Gc) and (ii) ?-1,3-galactose and its use as a medicament
    Type: Application
    Filed: April 17, 2014
    Publication date: March 17, 2016
    Applicant: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Jean-Paul Soulillou, Magali Giral, Gregoire Couvrat-Desvergnes